Ghent, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Press release
Biotalys to Participate in Upcoming Investor and Stakeholder Events
Ghent, BELGIUM – 21 September 2021 – Biotalys (Euronext - BTLS), an AgTech company focused on addressing food protection challenges to enable a more sustainable and safer food supply, today announces that it will be presenting at the following events during the remainder of 2021:
Bryan-Garnier Food Tech Virtual Conference, 23-24 September
CEO Patrice Sellès and CFO Wim Ottevaere will be speaking at Bryan Garnier & Co.’s Food Tech Conference on Friday 24 September at 15:00 CEST to an international audience of investors, with a presentation and Q&A session.
Knowledge for Growth (FlandersBio), 28 September
Biotalys will give a company presentation and participate in a panel debate on Europe’s Farm to Fork strategy at Knowledge for Growth on Tuesday 28 September 2021, at 14:00 CEST. The conference takes place in Ghent and is attended by decision makers from the biotech, pharma and medtech, agricultural and chemical industries as well as investors, universities and research institutes.
VIB 25 Year Anniversary, 13 October
Biotalys will feature as one of the key spinoffs at the event in Brussels for the 25th anniversary of VIB, the Flemish Institute for Biotechnology.
Congreso Redagrícola Biocontrol, 13-15 October
Carlos Reyes, Field Prodcut Development Manager at Biotalys, will be giving a talk in this online conference. The Latin America-based event will span over three days, with workshops, roundtables and keynote lectures.
VFB Happening 2021, 23 October
Wim Ottevaere, CFO, and Toon Musschoot, Head IR & Communication, will represent Biotalys in a booth at this retail investor conference in Kinepolis, Antwerp.
Food Tech Congress, 3-4 November
CEO Patrice Sellès will speak at the AgriTech session during this year's FoodTech Congress on Thursday 4 November 2021.
Kepler Cheuvreux’s Global Agri Forum, 15 November
Biotalys' CEO, Patrice Sellès, and CFO, Wim Ottevaere, will speak with investors at this year's Global Agri Forum organised by Kepler Cheuvreux (virtual format).
Deutsches Eigenkapitalforum, 22-24 November
Biotalys' management will give a company presentation at the Deutsches Eigenkapitalforum (EKF) on Wednesday 24 November 2021 at 14:00 CEST (virtual format).
KBC Securities Small & Mid Cap Conference, 9-10 December
Biotalys will participate in this event for institutional investors in Brussels. CEO, Patrice Sellès, CFO, Wim Ottevaere and Toon Musschoot, Head IR & Communication, will represent the company.
- ENDS -
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys has developed a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since 2 July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact:
Toon Musschoot, Head of Investor Relations & Communications
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com
Consilium Strategic Communications
Amber Fennell
T: +44 (0)203 709 5700
E: Biotalys@consilium-comms.com
Important Notice
This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ‘aim’, 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
